Skip to content

The effect of hypnotherapy on irritable bowel syndrome

The effect of hypnotherapy on gastrointestinal symptoms severity,anxiety scores and quality of life in patients with irritable bowel syndrome.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201102264775N2
Enrollment
100
Registered
2015-06-15
Start date
2010-12-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrom. irritable bowel syndrome

Interventions

Intervention 1: After obtaining the written letter of satisfaction to take part in the research and completing demographic questionnaire by physician, the usual treatment (drug-therapy) was started f
Treatment - Drugs
After obtaining the written letter of satisfaction to take part in the research and completing demographic questionnaire by physician, the usual treatment (drug-therapy) was started for patients and
Hypnotherapy did not carry out for control group.

Sponsors

University of Medical Scienecs Shiraz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having ages between 20 to 60 years; possessing the literacy of at least primary fifth class; IBS diagnosis by gastroenterologist; having at least three months history of suffering from IBS disease and being under the IBS usual therapeutic program; showing propensity of participating in hypnotherapy sessions and filling the written letter of satisfaction. Exclusion criteria: suffering from other gastrointestinal diseases or recognized psychical disease; being under other therapeutic programs like homeopathy, relaxation etc.; having the symptoms of reflux and functional dyspepsia; cancer history in individual or family; having anemia and positive stool test for parasite or blood

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of Life. Timepoint: 3 weeks before intervention,The begining of forth week ,The begining of sixth week,The begining of fifth week. Method of measurement: IBS specific quality of life.;Anxiety. Timepoint: 3 weeks before intervention,The begining of forth week ,The begining of sixth week,The begining of fifth week. Method of measurement: Spielberger State Trait Anxiety Inventory(SSTAI).;Gastrointestinal symptoms included abdominal pain, feeling cramp above abdomen, nausea and vomiting, borborygmus, abdominal distension, constipation, diarrhea, loose stool, solid stool, feeling urgent defecation and feeling tenesmus. Timepoint: 3 weeks before intervention,The begining of forth week ,The begining of sixth week,The begining of fifth week. Method of measurement: Gastrointestinal Symptom Rating Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZinat Mohebbi

Shiraz University of Medical Sciences

mohebbi04@yahoo.com+98 71 3647 4254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026